1113 Two drug classes that significantly reduce major adverse cardiovascular events (MACE) and death, regardless of the presence of T2D, are sodiumglucose co-transporter inhibitors (SGLTis) and glucagon-like peptide-1 (GLP-1) receptor agonists (RAs)
Apply one patch weeklyno side effects, just progress
Neuropilin-1-mediated SARS-CoV-2 infection in bone marrow-derived macrophages inhibits osteoclast differentiation
134 A randomized placebo-controlled trial in 120 subjects who described their sleep as unsatisfactory found treatment with 14 mg or 28 mg of a standardized saffron extract, taken one hour before bedtime for 28 days, improved subjective sleep quality and mood scores
Semaglutide follows a gradual titration schedule for weight loss
In conclusion, tirzepatide increased blood pressure and sympathetic activity in hypertensive rats without cardiac protection, highlighting context-dependent cardiovascular actions